NCT02915939

Brief Summary

Emerging research on family caregiving and institutionalization has emphasized that families do not disengage from care responsibilities following a relative's admission to residential long-term care settings. The Residential Care Transition Module (RCTM) provides 6 formal sessions of consultation (one-to-one and family sessions) over a 4-month period to those family caregivers who have admitted a cognitively impaired relative to a residential long-term care setting (nursing home, assisted living memory care unit). The proposed mixed method, randomized controlled trial will determine whether and how the RCTM decreases family caregivers' emotional and psychological distress, placement-related strain, and increases relative's transitions back to the community. The RCTM will fill an important clinical and research gap by evaluating a psychosocial intervention designed for families following RLTC placement to determine whether and how this approach can help families better navigate the residential care transitions of relatives with Alzheimer's disease or a related dementia.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
240

participants targeted

Target at P75+ for not_applicable alzheimer-disease

Timeline
Completed

Started Dec 2016

Longer than P75 for not_applicable alzheimer-disease

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 19, 2016

Completed
8 days until next milestone

First Posted

Study publicly available on registry

September 27, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

December 1, 2016

Completed
4.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 14, 2021

Completed
4 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 30, 2021

Completed
Last Updated

August 3, 2022

Status Verified

July 1, 2022

Enrollment Period

4.5 years

First QC Date

September 19, 2016

Last Update Submit

July 29, 2022

Conditions

Keywords

Family caregivingInstitutionalizationResidential long-term carePlacementPsychosocial supportDementiaCaregiversNursing homesAssisted Living FacilitiesLong-Term CareIntervention StudyPsychosocial Support SystemsSocial SupportCopingCOVID-19

Outcome Measures

Primary Outcomes (3)

  • Change in care-related strain

    A 7-item measure of care-related strain that assesses the stress family caregivers perceive as a result of having a relative in residential care

    12 months

  • Change in burden: Zarit Burden Interview

    A 7-item version of the Zarit Burden Interview

    12 months

  • Change in stress: Perceived Stress Scale

    The Perceived Stress Scale

    12 months

Secondary Outcomes (2)

  • Quantitative measure of resilience to negative psychosocial effects of COVID-19

    0, 1 and 4 months post-pandemic onset

  • Qualitative measure of resilience to negative psychosocial effects of COVID-19

    0, 1 and 4 months post-pandemic onset

Study Arms (2)

Treatment Group

EXPERIMENTAL

The Residential Care Transition Module (RCTM) includes six in-person consultation sessions over a 4-month period conducted by a trained Transition Counselor (TC) with a primary family caregiver (self-identified as the person most responsible for providing on-going assistance to the care recipient in a residential long-term care setting such (RLTC) such as a nursing home or assisted living memory care unit.

Behavioral: The Residential Care Transition Module

Usual Care Group

NO INTERVENTION

The usual care control group will adjust for the social engagement provided to the Residential Care Transition Module (RCTM )treatment condition. The Transition Counselor (TC) will provide quarterly contact calls and the research coordinator will send a bi-annual project newsletter to all participants. If caregivers in the control group initiate contact with the TC for care needs, the TC will provide information and referral support.

Interventions

Residential Care Transition Module sessions focus on the experiences of the caregiver, the care recipient, and (potentially) other family members immediately following residential long-term care (RLTC) admission. The sessions are designed to establish a therapeutic rapport with the caregiver and the family; provide a safe environment to explore stressors; examine family relational dynamics as they relate to the RLTC placement decision itself as well as the roles different family members play in the life of the caregiver and relative in RLTC; identify new modes of communication to facilitate more effective interactions with other family members and care staff; and identify effective ways to advocate for improved quality of care for and quality of life of their relatives in RLTC.

Treatment Group

Eligibility Criteria

Age21 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Family caregivers of relatives who have received a physician's diagnosis of Alzheimer's disease or a related dementia (ADRD)
  • Family caregivers who consider themselves the most involved in visiting and providing assistance to a relative experiencing a long-stay admission to an assisted living, nursing home, memory care, or other residential long-term care setting. Those who share the primary caregiving role equally are also eligible.
  • Family caregivers must be English speaking, 21 years of age or older
  • Family caregivers on psychotropic medications, such as anti-depressants or anti-psychotics, will be eligible if they have remained on a stable dosage for the last 3 months

You may not qualify if:

  • Family caregivers who are participating in any other type of service that provides one-to-one psychosocial consultation specifically for caregiving (support group participation is not a deterrent to enrollment, nor is general counseling not specific to caregiving)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Minnesota, School of Nursing, 6-153 Weaver-Densford Hall

Minneapolis, Minnesota, 55455, United States

Location

Related Publications (5)

  • Zmora R, Statz TL, Birkeland RW, McCarron HR, Finlay JM, Rosebush CE, Gaugler JE. Transitioning to Long-Term Care: Family Caregiver Experiences of Dementia, Communities, and Counseling. J Aging Health. 2021 Jan;33(1-2):133-146. doi: 10.1177/0898264320963588. Epub 2020 Sep 29.

    PMID: 32990494BACKGROUND
  • Gaugler JE, Statz TL, Birkeland RW, Louwagie KW, Peterson CM, Zmora R, Emery A, McCarron HR, Hepburn K, Whitlatch CJ, Mittelman MS, Roth DL. The ResidentialCare Transition Module: a single-blinded randomized controlled evaluation of a telehealth support intervention for family caregivers of persons with dementia living in residential long-term care. BMC Geriatr. 2020 Apr 15;20(1):133. doi: 10.1186/s12877-020-01542-7.

    PMID: 32293314BACKGROUND
  • Mitchell LL, Albers EA, Birkeland RW, Peterson CM, Stabler H, Horn B, Cha J, Drake A, Gaugler JE. Caring for a Relative With Dementia in Long-Term Care During COVID-19. J Am Med Dir Assoc. 2022 Mar;23(3):428-433.e1. doi: 10.1016/j.jamda.2021.11.026. Epub 2021 Dec 17.

    PMID: 34929196BACKGROUND
  • Gaugler JE, Mitchell LL. Reimagining Family Involvement in Residential Long-Term Care. J Am Med Dir Assoc. 2022 Feb;23(2):235-240. doi: 10.1016/j.jamda.2021.12.022. Epub 2021 Dec 29.

    PMID: 34973167BACKGROUND
  • Urbanski DP, Birkeland RW, Albers EA, Roth DL, Baker ZG, Gustavson AM, Yam H, Gaugler JE. Process evaluation of the residential care transition module. BMC Health Serv Res. 2025 Oct 27;25(1):1412. doi: 10.1186/s12913-025-13547-2.

MeSH Terms

Conditions

Alzheimer DiseaseDementiaCOVID-19

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesTauopathiesNeurodegenerative DiseasesNeurocognitive DisordersMental DisordersPneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Joseph E. Gaugler, PhD

    University of Minnesota

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
SUPPORTIVE CARE
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 19, 2016

First Posted

September 27, 2016

Study Start

December 1, 2016

Primary Completion

May 14, 2021

Study Completion

August 30, 2021

Last Updated

August 3, 2022

Record last verified: 2022-07

Data Sharing

IPD Sharing
Will share

The de-identified data supporting our findings will be shared on the National Archive of Computerized Data on Aging (NACDA).

Shared Documents
STUDY PROTOCOL, SAP

Locations